These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2219289)

  • 1. Dissociation of tissue destruction induced by cytolytic T cells in vivo and cytotoxicity as measured in vitro.
    Steinmuller D; Snider ME; Noble RL; Waldschmidt TJ
    Transplantation; 1990 Oct; 50(4):663-8. PubMed ID: 2219289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking of interleukin-2 production, but not the tissue destruction induced by cytotoxic T cells, by cyclosporine.
    Noble RL; Steinmuller D
    Transplantation; 1989 Feb; 47(2):322-6. PubMed ID: 2784016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue destruction resulting from the interaction of cytotoxic T cells and their targets.
    Steinmuller D; Tyler JD; Snider ME; Noble RL; Riser BL; Maassab HF; Galli SJ
    Ann N Y Acad Sci; 1988; 532():106-18. PubMed ID: 3052207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediation of skin allograft rejection in scid mice by CD4+ and CD8+ T cells.
    Shelton MW; Walp LA; Basler JT; Uchiyama K; Hanto DW
    Transplantation; 1992 Aug; 54(2):278-86. PubMed ID: 1353912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo cytotoxicity of T cells cloned from rejecting allografts.
    Snider ME; Armstrong L; Hudson JL; Steinmuller D
    Transplantation; 1986 Aug; 42(2):171-7. PubMed ID: 2426846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes.
    Bishop DK; Chan S; Li W; Ensley RD; Xu S; Eichwald EJ
    Transplantation; 1993 Oct; 56(4):892-7. PubMed ID: 8212213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo mechanisms of alloreactivity. I. Frequency of donor-reactive cytotoxic T lymphocytes in sponge matrix allografts.
    Orosz CG; Zinn NE; Sirinek L; Ferguson RM
    Transplantation; 1986 Jan; 41(1):75-83. PubMed ID: 2934878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK; Shelby J; Eichwald EJ
    Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of intragraft interleukin-2-activated killer cells and allospecific cytolytic T lymphocytes in rejecting lung allografts.
    Norin AJ; Kamholz SL
    Transplantation; 1989 Nov; 48(5):856-62. PubMed ID: 2530670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative importance of cytotoxic T lymphocytes and nitric oxide-dependent cytotoxicity in contractile dysfunction of rejecting murine cardiac allografts.
    Menon SG; Zhao L; Xu S; Samlowski WE; Shelby J; McGregor J; Barry WH
    Transplantation; 1998 Aug; 66(4):413-9. PubMed ID: 9734481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
    Ildstad ST; Wren SM; Oh E; Hronakes ML
    Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo mechanisms of alloreactivity. II. Allospecificity of cytotoxic T lymphocytes in sponge matrix allografts as determined by limiting dilution analysis.
    Orosz CG; Zinn NE; Sirinek LP; Ferguson RM
    Transplantation; 1986 Jan; 41(1):84-92. PubMed ID: 2934879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
    Matoba AY; Peeler JS; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
    Yoshimura A; Shiku H; Nakayama E
    J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal analysis of the lymphoid cells mediating skin allograft rejection. Mediation of graft rejection in vivo by cloned Lyt-1+2- proliferative, noncytotoxic long-term cell lines.
    Kim B; Rosenstein M; Weiland D; Eberlein TJ; Rosenberg SA
    Transplantation; 1983 Nov; 36(5):525-32. PubMed ID: 6356516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human in vivo cytotoxic T lymphocyte generation by cyclosporine following organ transplantation.
    Keown PA; Essery-Rice G; Hellstrom A; Sinclair NR; Stiller CR
    Transplantation; 1985 Jul; 40(1):45-9. PubMed ID: 3892796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo.
    Rosenberg AS; Munitz TI; Maniero TG; Singer A
    J Exp Med; 1991 Jun; 173(6):1463-71. PubMed ID: 1674524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogenous graft rejection pathways in class I major histocompatibility complex-disparate combinations and their differential susceptibility to immunomodulation induced by intravenous presensitization with relevant alloantigens.
    Kitagawa S; Iwata H; Sato S; Shimizu J; Hamaoka T; Fujiwara H
    J Exp Med; 1991 Sep; 174(3):571-81. PubMed ID: 1678775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity.
    Bhat P; Leggatt G; Waterhouse N; Frazer IH
    Cell Death Dis; 2017 Jun; 8(6):e2836. PubMed ID: 28569770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.